JP2024514362A5 - - Google Patents
Info
- Publication number
- JP2024514362A5 JP2024514362A5 JP2023564654A JP2023564654A JP2024514362A5 JP 2024514362 A5 JP2024514362 A5 JP 2024514362A5 JP 2023564654 A JP2023564654 A JP 2023564654A JP 2023564654 A JP2023564654 A JP 2023564654A JP 2024514362 A5 JP2024514362 A5 JP 2024514362A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- pain
- composition according
- approximately
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163177981P | 2021-04-22 | 2021-04-22 | |
| US63/177,981 | 2021-04-22 | ||
| PCT/IB2022/053730 WO2022224184A1 (en) | 2021-04-22 | 2022-04-21 | Transdermal pharmaceutical formulations for the treatment of chronic pain |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024514362A JP2024514362A (ja) | 2024-04-01 |
| JP2024514362A5 true JP2024514362A5 (https=) | 2025-04-28 |
Family
ID=83722736
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023564654A Pending JP2024514362A (ja) | 2021-04-22 | 2022-04-21 | 慢性疼痛の処置のための経皮医薬製剤 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20220347151A1 (https=) |
| EP (1) | EP4326252A4 (https=) |
| JP (1) | JP2024514362A (https=) |
| CN (1) | CN117545478A (https=) |
| AU (1) | AU2022260813A1 (https=) |
| CA (1) | CA3215685A1 (https=) |
| MX (1) | MX2023012483A (https=) |
| WO (1) | WO2022224184A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4041209A4 (en) | 2019-10-11 | 2024-01-24 | Pike Therapeutics, Inc. | TRANSDERMAL COMPOSITIONS COMPRISING CANNABIDIOL (CBD) FOR USE IN THE TREATMENT OF EPILEPTIC DISORDERS |
| CN119896633A (zh) * | 2025-01-17 | 2025-04-29 | 中国人民解放军空军军医大学 | 一种水凝胶冷敷贴及其制备的冷热敷贴套装和应用 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR19990026792A (ko) * | 1997-09-26 | 1999-04-15 | 김윤 | 디클로페낙 디에틸암모늄염을 함유한 매트릭스형 패취제제 |
| CA2760460C (en) * | 2009-04-28 | 2019-04-02 | Alltranz Inc. | Transdermal formulations of cannabidiol comprising a penetration enhancer and methods of using the same |
| PT2473475T (pt) * | 2009-08-31 | 2017-08-02 | Zynerba Pharmaceuticals Inc | Utilização de profármacos de canabidiol na administração tópica e transdérmica com microagulhas |
| US20160022627A2 (en) * | 2014-04-18 | 2016-01-28 | Mary's Medicinals LLC | Transdermal cannabinoid patch |
| US10272125B2 (en) * | 2015-09-14 | 2019-04-30 | Life Tech Global, Llc | Transdermal delivery of cannabidiol with other active moieties including cannabinoids |
| CN108697665A (zh) * | 2015-09-30 | 2018-10-23 | 乔治·爱德华·霍格 | 局部镇痛性疼痛缓解制剂、其制备和使用方法 |
| EP3538122B1 (en) * | 2016-11-14 | 2025-03-26 | Farm To Farma, Inc. | Cannabinoid formulations and method of making the same |
| US10966946B2 (en) * | 2016-11-17 | 2021-04-06 | Cmpd Licensing, Llc | Compounded compositions and methods for treating pain |
| BR112020014253A2 (pt) * | 2018-01-12 | 2020-12-08 | Nutrae, LLC | Formulações de canabinóides encapsuladas para administração oral |
| CA3060926A1 (en) * | 2018-09-06 | 2020-03-06 | NuVessl, Inc. | Method of using cannabinoids encapsulated in phospholipid carriers for transmucosal and transdermal administration |
| US20200197359A1 (en) * | 2018-09-17 | 2020-06-25 | Cody D. Freeze | Cannabinoid and Terpene-Infused Topical Cream |
| US12403114B2 (en) * | 2019-03-12 | 2025-09-02 | Epm (Ip), Inc. | Cannabinoid acid ester compositions and uses thereof |
| WO2020263643A1 (en) * | 2019-06-28 | 2020-12-30 | Nexzol Pharma, Inc. | Transdermal formulations |
| AU2020358869A1 (en) * | 2019-10-03 | 2022-04-14 | Pike Therapeutics Usa, Inc. | Transdermal delivery of dronabinol |
| EP4041209A4 (en) * | 2019-10-11 | 2024-01-24 | Pike Therapeutics, Inc. | TRANSDERMAL COMPOSITIONS COMPRISING CANNABIDIOL (CBD) FOR USE IN THE TREATMENT OF EPILEPTIC DISORDERS |
| US12016829B2 (en) * | 2019-10-11 | 2024-06-25 | Pike Therapeutics Inc. | Pharmaceutical composition and method for treating seizure disorders |
| US12121617B2 (en) * | 2019-10-14 | 2024-10-22 | Pike Therapeutics Inc. | Transdermal delivery of cannabidiol |
| CA3155181A1 (en) * | 2019-10-14 | 2021-04-22 | Pike Therapeutics, Inc., 1219014 B.C. Ltd. | Transdermal delivery of cannabidiol |
| CA3178878A1 (en) * | 2020-04-20 | 2021-10-28 | Fotios M. Plakogiannis | Transdermal and/or topical pharmaceutical formulations comprising cannabidiol and/or tetrahydrocannabinol for the treatment of chronic pain |
| WO2022003623A1 (en) * | 2020-07-01 | 2022-01-06 | Pike Therapeutics, Inc. | Transdermal pharmaceutical formulations for the treatment of multiple sclerosis |
| US20220047525A1 (en) * | 2020-08-17 | 2022-02-17 | Pike Therapeutics, Inc. | Transdermal pharmaceutical formulations of nabilone alone and in combination with cannabinoids |
| CN117337174A (zh) * | 2020-12-03 | 2024-01-02 | 长矛治疗股份有限公司 | 用于治疗癌症的包含cbd或thc的透皮药物制剂 |
-
2022
- 2022-04-21 CN CN202280044571.8A patent/CN117545478A/zh active Pending
- 2022-04-21 MX MX2023012483A patent/MX2023012483A/es unknown
- 2022-04-21 WO PCT/IB2022/053730 patent/WO2022224184A1/en not_active Ceased
- 2022-04-21 US US17/725,593 patent/US20220347151A1/en not_active Abandoned
- 2022-04-21 CA CA3215685A patent/CA3215685A1/en active Pending
- 2022-04-21 JP JP2023564654A patent/JP2024514362A/ja active Pending
- 2022-04-21 AU AU2022260813A patent/AU2022260813A1/en not_active Abandoned
- 2022-04-21 EP EP22791231.8A patent/EP4326252A4/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6283392B2 (ja) | 勃起不全および他の適応症の処置 | |
| JP2023523155A5 (https=) | ||
| AU2005251805B2 (en) | Dermal peel-forming formulation | |
| US20140004176A1 (en) | Delivery of treatments transdermally for fungal infections and other indications | |
| JP2016033168A (ja) | Ｃｏｘ−２阻害剤および関連化合物、ならびにそれらを送達するためのシステムおよび方法 | |
| US20050187212A1 (en) | Pharmaceutical composition for topical delivery of meloxicam | |
| JP2022551730A5 (https=) | ||
| JP2016153434A (ja) | 片頭痛および他の適応症の処置のための方法およびシステム | |
| JP2024514362A5 (https=) | ||
| US9289495B2 (en) | Systems and methods for treatment of allergies and other indications | |
| WO2014152382A1 (en) | Transdermal delivery of sildenafil and other phosphodiesterase type 5 inhibitors | |
| JP2022550569A5 (https=) | ||
| ES2197077T3 (es) | Dispositivo transdermico que comprende farmacos anti-inflamatorios no esteroides incorporados en una matriz de un polimero acrilico adhesivo. | |
| KR20070059758A (ko) | 비스테로이드성 항염증제와 국소마취제를 포함하는 경피투여 조성물 | |
| WO1992020376A1 (fr) | Composition de promoteur de l'absorption percutanee et preparation externe pour l'administration de medicaments par voie percutanee | |
| CN1449282A (zh) | 烧伤的治疗 | |
| HK40039061B (en) | Treatment of erectile dysfunction | |
| FR2797766A1 (fr) | Nouvelles formes topiques a consistance pateuse sous forme d'un gel distribue en doses |